2nd Quarter - Amendment
TIBER CREEK HEALTH STRATEGIES, INC. for NOVARTIS
Client
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 14, 2023 | $60,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 18, 2023 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); S. 476 - Maintaining Investments in New Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Health Issues HCR
Issues related to pharmacy benefit managers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.